Clinical observation in the treatment of genitourinary syndrome of menopause with low dose tibolone

2021 ◽  
Vol 21 (3) ◽  
pp. 171-174
Author(s):  
Hui ZHANG ◽  
◽  
Chao HAN ◽  
Jinfeng ZENG
Author(s):  
George G Buttigieg ◽  
Kirill Micallef-Stafrace

The European Medicines Agency's Pharmacovigilance Risk Assessment Committee has issued statements regarding limiting the use of high-dose oestradiol creams by women experiencing the genitourinary syndrome of menopause, and such statements carry much medicolegal weight. Although a low dose is most often used, some clinicians opt to use higher dose creams with close monitoring of the patient. The committee should publish the evidence behind these statements or amend its official position.


Maturitas ◽  
2021 ◽  
Author(s):  
Eduard Mension ◽  
Inmaculada Alonso ◽  
Marta Tortajada ◽  
Isabel Matas ◽  
Sílvia Gómez ◽  
...  

Maturitas ◽  
2017 ◽  
Vol 103 ◽  
pp. 78-88 ◽  
Author(s):  
Eleni Pitsouni ◽  
Themos Grigoriadis ◽  
Matthew E. Falagas ◽  
Stefano Salvatore ◽  
Stavros Athanasiou

2021 ◽  
Vol 12 (2) ◽  
pp. 99
Author(s):  
Camil Castelo-Branco ◽  
Eduard Mension ◽  
Inmaculada Alonso ◽  
Marta Tortajada ◽  
Isabel Matas ◽  
...  

2018 ◽  
Vol 22 (5) ◽  
pp. 423-430 ◽  
Author(s):  
Ashley L. Hodges ◽  
Aimee C. Holland ◽  
Barbara Dehn ◽  
Diane T. Pace

Sign in / Sign up

Export Citation Format

Share Document